Passage Bio Competitors and Similar CompaniesClear all

Passage Bio's competitors and similar companies include Taysha Gene Therapies, Encoded Therapeutics, Gyroscope Therapeutics and Variant Bio.

	Passage Bio Passage Bio is a genetic medicines company developing therapies for the treatment of rare monogenic central nervous system diseases.	Taysha Gene Therapies Taysha Gene Therapies is a biotechnology company that develops therapies.	Encoded Therapeutics Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad range of severe genetic disorders.	Gyroscope Therapeutics Gyroscope Therapeutics Holdings is an ophthalmology company.	Variant Bio Variant Bio is a biotechnology company that develops human genetic diversity therapies.
Founding Date	Founding Date 2018	Founding Date 2020	Founding Date 2014	Founding Date 2016	Founding Date 2018
Type	Type Public	Type Public	Type Private	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech genetics therapy	Tags Healthcare biotech genetics therapy	Tags Healthcare biotech genetics therapy	Tags Healthcare biotech genetics therapy	Tags Healthcare biotech genetics therapy
Locations	Locations Philadelphia, US HQ	Locations Dallas, US HQ	Locations South San Francisco, US HQ	Locations Stevenage, GB HQ London, GB Ambler, US	Locations Seattle, US HQ
Employees	Employees 20	Employees 5220% decrease	Employees 1651% decrease	Employees 502% increase	Employees 47
Valuation ($)	Valuation ($) 39.4 m	Valuation ($) 385.3 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Net income	Net income ($45.5m) (FY, 2025)	Net income ($109m) (FY, 2025)	Net income N/A	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 225.5m	Total funding raised $ 125m	Total funding raised $ 239.1m	Total funding raised $ 205.7m	Total funding raised N/A